A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19

Alfred H.J. Kim, Jeffrey A. Sparks, Jean W. Liew, Michael S. Putman, Francis Berenbaum, Alí Duarte-García, Elizabeth R. Graef, Peter Korsten, Sebastian E. Sattui, Emily Sirotich, Manuel F. Ugarte-Gil, Kate Webb, Rebecca Grainger

Research output: Contribution to journalEditorial

47 Scopus citations
Original languageEnglish
Pages (from-to)819-821
Number of pages3
JournalAnnals of internal medicine
Volume172
Issue number12
DOIs
StatePublished - Jun 16 2020

Keywords

  • Antimalarials
  • Biomarkers
  • COVID-19
  • Chloroquine
  • Intensive care units
  • Metastasis
  • Polymerase chain reaction
  • Post-exposure prophylaxis
  • Safety
  • Viral load

Cite this

Kim, A. H. J., Sparks, J. A., Liew, J. W., Putman, M. S., Berenbaum, F., Duarte-García, A., Graef, E. R., Korsten, P., Sattui, S. E., Sirotich, E., Ugarte-Gil, M. F., Webb, K., & Grainger, R. (2020). A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Annals of internal medicine, 172(12), 819-821. https://doi.org/10.7326/M20-1223